tradingkey.logo

MiMedx Group Inc

MDXG
View Detailed Chart
6.900USD
-0.180-2.54%
Close 12/26, 16:00ETQuotes delayed by 15 min
1.02BMarket Cap
24.93P/E TTM

MiMedx Group Inc

6.900
-0.180-2.54%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.54%

5 Days

-2.13%

1 Month

+0.29%

6 Months

+16.16%

Year to Date

-28.27%

1 Year

-26.52%

View Detailed Chart

TradingKey Stock Score of MiMedx Group Inc

Currency: USD Updated: 2025-12-26

Key Insights

MiMedx Group Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 48/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.20.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

MiMedx Group Inc's Score

Industry at a Glance

Industry Ranking
48 / 404
Overall Ranking
133 / 4563
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 5 analysts
Buy
Current Rating
12.200
Target Price
+82.63%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

MiMedx Group Inc Highlights

StrengthsRisks
MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 30.26% year-on-year.
Overvalued
The company’s latest PE is 24.93, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 104.90M shares, decreasing 3.52% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 15.75K shares of this stock.

MiMedx Group Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

MiMedx Group Inc Info

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
Ticker SymbolMDXG
CompanyMiMedx Group Inc
CEOCapper (Joseph H)
Websitehttps://mimedx.com/

FAQs

What is the current price of MiMedx Group Inc (MDXG)?

The current price of MiMedx Group Inc (MDXG) is 6.900.

What is the symbol of MiMedx Group Inc?

The ticker symbol of MiMedx Group Inc is MDXG.

What is the 52-week high of MiMedx Group Inc?

The 52-week high of MiMedx Group Inc is 9.710.

What is the 52-week low of MiMedx Group Inc?

The 52-week low of MiMedx Group Inc is 5.790.

What is the market capitalization of MiMedx Group Inc?

The market capitalization of MiMedx Group Inc is 1.02B.

What is the net income of MiMedx Group Inc?

The net income of MiMedx Group Inc is 42.42M.

Is MiMedx Group Inc (MDXG) currently rated as Buy, Hold, or Sell?

According to analysts, MiMedx Group Inc (MDXG) has an overall rating of Buy, with a price target of 12.200.

What is the Earnings Per Share (EPS TTM) of MiMedx Group Inc (MDXG)?

The Earnings Per Share (EPS TTM) of MiMedx Group Inc (MDXG) is 0.277.
KeyAI